Swayampakula Ramakanth
Stock Analyst at HC Wainwright & Co.
(2.33)
# 2,567
Out of 4,761 analysts
428
Total ratings
40%
Success rate
-0.04%
Average return
Main Sectors:
Stocks Rated by Swayampakula Ramakanth
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| EVAX Evaxion Biotech | Reiterates: Buy | $14 | $2.53 | +453.36% | 11 | Feb 20, 2025 | |
| LFWD Lifeward | Reiterates: Buy | $13 | $1.77 | +636.54% | 6 | Feb 20, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 → $8 | $0.68 | +1,076.47% | 19 | Feb 13, 2025 | |
| INAB IN8bio | Reiterates: Buy | $8 | $0.27 | +2,846.59% | 14 | Feb 12, 2025 | |
| CORT Corcept Therapeutics | Maintains: Buy | $80 → $115 | $63.54 | +80.99% | 19 | Feb 11, 2025 | |
| XFOR X4 Pharmaceuticals | Reiterates: Buy | $1.5 | $0.47 | +221.13% | 14 | Feb 7, 2025 | |
| IPHA Innate Pharma | Reiterates: Buy | $12 | $2.24 | +413.39% | 14 | Feb 6, 2025 | |
| LPTX Leap Therapeutics | Downgrades: Neutral | n/a | $0.48 | - | 14 | Jan 29, 2025 | |
| PSNL Personalis | Maintains: Buy | $11 → $8 | $4.72 | +69.67% | 13 | Jan 27, 2025 | |
| ALXO ALX Oncology Holdings | Maintains: Buy | $25 → $5 | $1.12 | +346.43% | 13 | Jan 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $33 | $14.51 | +127.43% | 6 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 → $6 | $1.91 | +214.14% | 9 | Jan 23, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $4.96 | +41.13% | 13 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $110 | $79.49 | +38.38% | 2 | Jan 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $21 | $7.41 | +183.40% | 10 | Jan 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $60 | $52.00 | +15.38% | 17 | Jan 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5.5 | $1.71 | +221.64% | 6 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $6 | $0.61 | +887.82% | 7 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.55 | +1,541.14% | 13 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $22 | $14.88 | +47.85% | 11 | Jan 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $33 | $11.66 | +183.02% | 17 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $17.68 | +41.40% | 17 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 → $5 | $1.28 | +290.63% | 7 | Dec 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $25 | $17.67 | +41.48% | 12 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $7 | $0.39 | +1,713.00% | 8 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18 | $1.37 | +1,177.37% | 10 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $10 | $1.04 | +861.54% | 12 | Dec 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $63 → $70 | $36.01 | +94.39% | 11 | Dec 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $3.47 | +217.00% | 11 | Nov 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $2.23 | +124.22% | 2 | Nov 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $27 | $13.15 | +105.32% | 5 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.45 | - | 2 | Nov 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $40 | $23.67 | +68.99% | 4 | Nov 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $19 | $2.58 | +636.43% | 13 | Aug 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $3 → $0.95 | $0.91 | +4.42% | 4 | Aug 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $3.5 | $1.95 | +79.49% | 2 | Aug 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $11 | $7.98 | +37.84% | 8 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $20 | $2.35 | +751.06% | 1 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $5.78 | +55.71% | 1 | Dec 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.68 | - | 2 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.18 | - | 12 | May 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $9 | $0.96 | +839.95% | 1 | Feb 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $25 | $1.68 | +1,388.10% | 2 | Jan 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $2.06 | +142.72% | 1 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $0.31 | +1,184.52% | 1 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $12 | $2.45 | +389.80% | 2 | Aug 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $25 → $20 | $0.41 | +4,800.76% | 2 | Aug 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.47 | - | 8 | May 13, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $150 → $80 | $1.78 | +4,394.38% | 5 | Feb 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9.5 → $6 | $4.19 | +43.20% | 4 | Jul 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $15 | $8.59 | +74.62% | 5 | Nov 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $30 → $33 | $5.68 | +480.99% | 1 | Mar 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $8 → $9.5 | $10.61 | -10.46% | 3 | Mar 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $18,000 → $14,000 | $4.76 | +294,017.65% | 1 | Mar 5, 2020 |
Evaxion Biotech
Feb 20, 2025
Reiterates: Buy
Price Target: $14
Current: $2.53
Upside: +453.36%
Lifeward
Feb 20, 2025
Reiterates: Buy
Price Target: $13
Current: $1.77
Upside: +636.54%
Ocugen
Feb 13, 2025
Maintains: Buy
Price Target: $7 → $8
Current: $0.68
Upside: +1,076.47%
IN8bio
Feb 12, 2025
Reiterates: Buy
Price Target: $8
Current: $0.27
Upside: +2,846.59%
Corcept Therapeutics
Feb 11, 2025
Maintains: Buy
Price Target: $80 → $115
Current: $63.54
Upside: +80.99%
X4 Pharmaceuticals
Feb 7, 2025
Reiterates: Buy
Price Target: $1.5
Current: $0.47
Upside: +221.13%
Innate Pharma
Feb 6, 2025
Reiterates: Buy
Price Target: $12
Current: $2.24
Upside: +413.39%
Leap Therapeutics
Jan 29, 2025
Downgrades: Neutral
Price Target: n/a
Current: $0.48
Upside: -
Personalis
Jan 27, 2025
Maintains: Buy
Price Target: $11 → $8
Current: $4.72
Upside: +69.67%
ALX Oncology Holdings
Jan 24, 2025
Maintains: Buy
Price Target: $25 → $5
Current: $1.12
Upside: +346.43%
Jan 23, 2025
Maintains: Buy
Price Target: $17 → $33
Current: $14.51
Upside: +127.43%
Jan 23, 2025
Reiterates: Buy
Price Target: $4 → $6
Current: $1.91
Upside: +214.14%
Jan 17, 2025
Reiterates: Buy
Price Target: $7
Current: $4.96
Upside: +41.13%
Jan 17, 2025
Reiterates: Buy
Price Target: $110
Current: $79.49
Upside: +38.38%
Jan 16, 2025
Reiterates: Buy
Price Target: $21
Current: $7.41
Upside: +183.40%
Jan 15, 2025
Reiterates: Buy
Price Target: $60
Current: $52.00
Upside: +15.38%
Jan 14, 2025
Reiterates: Buy
Price Target: $5.5
Current: $1.71
Upside: +221.64%
Jan 14, 2025
Reiterates: Buy
Price Target: $6
Current: $0.61
Upside: +887.82%
Jan 14, 2025
Reiterates: Buy
Price Target: $9
Current: $0.55
Upside: +1,541.14%
Jan 14, 2025
Reiterates: Buy
Price Target: $22
Current: $14.88
Upside: +47.85%
Jan 13, 2025
Reiterates: Buy
Price Target: $33
Current: $11.66
Upside: +183.02%
Jan 10, 2025
Reiterates: Buy
Price Target: $25
Current: $17.68
Upside: +41.40%
Dec 20, 2024
Reiterates: Buy
Price Target: $7 → $5
Current: $1.28
Upside: +290.63%
Dec 18, 2024
Maintains: Buy
Price Target: $22 → $25
Current: $17.67
Upside: +41.48%
Dec 11, 2024
Maintains: Buy
Price Target: $9 → $7
Current: $0.39
Upside: +1,713.00%
Dec 10, 2024
Reiterates: Buy
Price Target: $18
Current: $1.37
Upside: +1,177.37%
Dec 10, 2024
Reiterates: Buy
Price Target: $10
Current: $1.04
Upside: +861.54%
Dec 3, 2024
Maintains: Buy
Price Target: $63 → $70
Current: $36.01
Upside: +94.39%
Nov 29, 2024
Reiterates: Buy
Price Target: $11
Current: $3.47
Upside: +217.00%
Nov 21, 2024
Reiterates: Buy
Price Target: $5
Current: $2.23
Upside: +124.22%
Nov 15, 2024
Reiterates: Buy
Price Target: $27
Current: $13.15
Upside: +105.32%
Nov 15, 2024
Downgrades: Neutral
Price Target: n/a
Current: $1.45
Upside: -
Nov 11, 2024
Reiterates: Buy
Price Target: $40
Current: $23.67
Upside: +68.99%
Aug 29, 2024
Reiterates: Buy
Price Target: $19
Current: $2.58
Upside: +636.43%
Aug 23, 2024
Downgrades: Neutral
Price Target: $3 → $0.95
Current: $0.91
Upside: +4.42%
Aug 13, 2024
Reiterates: Buy
Price Target: $3.5
Current: $1.95
Upside: +79.49%
May 1, 2024
Reiterates: Buy
Price Target: $11
Current: $7.98
Upside: +37.84%
Apr 1, 2024
Reiterates: Buy
Price Target: $20
Current: $2.35
Upside: +751.06%
Dec 8, 2023
Initiates: Buy
Price Target: $9
Current: $5.78
Upside: +55.71%
Aug 16, 2023
Downgrades: Neutral
Price Target: n/a
Current: $1.68
Upside: -
May 9, 2023
Downgrades: Neutral
Price Target: n/a
Current: $4.18
Upside: -
Feb 17, 2023
Reiterates: Buy
Price Target: $9
Current: $0.96
Upside: +839.95%
Jan 30, 2023
Maintains: Buy
Price Target: $150 → $25
Current: $1.68
Upside: +1,388.10%
Dec 7, 2022
Initiates: Buy
Price Target: $5
Current: $2.06
Upside: +142.72%
Nov 4, 2022
Maintains: Buy
Price Target: $3 → $4
Current: $0.31
Upside: +1,184.52%
Aug 15, 2022
Maintains: Buy
Price Target: $3 → $12
Current: $2.45
Upside: +389.80%
Aug 10, 2022
Maintains: Buy
Price Target: $25 → $20
Current: $0.41
Upside: +4,800.76%
May 13, 2022
Downgrades: Neutral
Price Target: n/a
Current: $19.47
Upside: -
Feb 17, 2022
Maintains: Buy
Price Target: $150 → $80
Current: $1.78
Upside: +4,394.38%
Jul 16, 2021
Maintains: Buy
Price Target: $9.5 → $6
Current: $4.19
Upside: +43.20%
Nov 9, 2020
Maintains: Buy
Price Target: $20 → $15
Current: $8.59
Upside: +74.62%
Mar 16, 2020
Maintains: Buy
Price Target: $30 → $33
Current: $5.68
Upside: +480.99%
Mar 6, 2020
Reiterates: Buy
Price Target: $8 → $9.5
Current: $10.61
Upside: -10.46%
Mar 5, 2020
Reiterates: Buy
Price Target: $18,000 → $14,000
Current: $4.76
Upside: +294,017.65%